Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.
Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.
The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.
A slight flaw in a study on the effectiveness of a drug widely used to combat shock in critically injured patients almost gets a Danish researcher sued for millions.
A new study suggests that a drug for blood poisoning that was withdrawn by its manufacturer does work after all.
Page 1 of 1